Sign In
Buy CGEN
$2.34
-0.0700 (-2.90%)
At Close: Aug 10, 2026
Compugen (NASDAQ:CGEN) Sets New 12-Month High at $14.61
09:44am, Thursday, 23'rd Apr 2020
Shares of Compugen Ltd. (NASDAQ:CGEN) hit a new 52-week high during trading on Tuesday . The stock traded as high as $14.61 and last traded at $13.73, with a volume of 519391 shares traded. The stock
CMG, CLDX among premarket gainers
01:19pm, Wednesday, 22'nd Apr 2020
SAExploration Holdings (NASDAQ:SAEX) +177% on $27M new project in Greece.B.O.S. Better Online Solutions (NASDAQ:BOSC) +56% on $1M order.The Peck Company Holdings (NASDAQ:PECK) +51% on partnership w
Compugen Expands Intellectual Property Portfolio for COM701 With New European Composition of Matter Patent
12:22pm, Wednesday, 22'nd Apr 2020
Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery, announced today that The European Patent Office (EPO) has granted the Company a n
BofA likes Johnson & Johnson in premarket analyst action
11:38am, Wednesday, 22'nd Apr 2020
Adaptimmune (NASDAQ:ADAP) initiated with Neutral rating and $3 (17% downside risk) price target at Mizuho Securities.Autolus Therapeutics (NASDAQ:AUTL) initiated with Buy rating and $18 (90% upside) p
17 Healthcare Stocks Moving In Wednesday's Pre-Market Session
11:38am, Wednesday, 22'nd Apr 2020Stocks That Hit 52-Week Highs On Tuesday
02:30pm, Tuesday, 21'st Apr 2020
On Tuesday, 27 stocks hit new 52-week highs.
Highlights:
The largest company by market cap to set a new 52-week high was Vertex Pharmaceuticals (NASDAQ: VRTX).
The...
M&T Bank reports Q1 non-GAAP EPS $1.95, consensus $2.47 MTB
11:24am, Monday, 20'th Apr 2020
M&T Bank reports Q1 non-GAAP EPS $1.95, consensus $2.47 MTB
Compugen Announces Publication of BAY 1905254 Preclinical Data in Cancer Immunology Research
11:00am, Monday, 20'th Apr 2020
Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery, announced today the publication of a peer reviewed paper titled "Characterization
Compugen Announces Publication of a Peer Reviewed Paper on its Cancer Immunology Research
12:00am, Monday, 20'th Apr 202070 Biggest Movers From Yesterday
08:53am, Friday, 17'th Apr 2020
Gainers
Arcus Biosciences, Inc. (NASDAQ: RCUS) shares surged 89.4% to close at $29.50 on Thursday amid Bloomberg report that Gilead is holding talks to take a stake in company....
52 Stocks Moving In Thursday's Mid-Day Session
04:58pm, Thursday, 16'th Apr 2020
Gainers
Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares climbed 167.8% to $92.90.
Edison Nation Inc (NASDAQ: EDNT) shares climbed 97.6% to $3.30 after the company...
52 Stocks Moving In Thursday's Mid-Day Session
04:57pm, Thursday, 16'th Apr 2020
Gainers
Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares climbed 167.8% to $92.90.
Edison Nation Inc (NASDAQ: EDNT) shares climbed 97.6% to $3.30 after the company...
Cancer Drug Maker Arcus Surgesas Street Touts$10 Billion Opportunity With Gilead
04:24pm, Thursday, 16'th Apr 2020
(Bloomberg) -- Arcus Biosciences Inc., which is working in a category of new cancer medicines estimated to be worth as much $10 billion, nearly doubled after Bloomberg reported that Gilead Sciences In
